Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
SPRB · NASDAQ · Pharmaceutical Preparations
$38.00−2.49 (−6.15%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Spruce Biosciences (SPRB) · oqro.io/stocks/SPRB · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Fund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Carlyle Group Inc. disclosed a reduced position in SPRB for Q4 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 7, 2025
Carlyle Group Inc. disclosed a new position in SPRB for Q3 2025SourceInsider trade · Traded Oct 6, 2025 · Filed Oct 9, 2025
10% owner purchased ~$4.6K of SPRB shares in the open marketSourceInsider trade · Traded Oct 6, 2025 · Filed Oct 9, 2025
10% owner sold ~$4.5K of SPRB shares in the open marketSourceInsider trade · Traded Oct 6, 2025 · Filed Oct 9, 2025
10% owner sold ~$436 of SPRB shares in the open marketSource